Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Newling

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Progress in Clinical and Biological Research|January 1, 1985
Proteinuria after intravesical chemotherapyE H Cooper, H Yu, R W Glashan, et al.
British Journal of Urology|December 1, 1988
The value of the measurement of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancerT G Armitage, E H Cooper, D W Newling, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 24, 2001
Chronic cystitis caused by Corynebacterium urealyticum detected by polymerase chain reactionA M Simoons-Smit, P H Savelkoul, D W Newling, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1992
Prognostic factors in hormone-resistant progressing cancer of the prostateS D Fosså, D P Dearnaley, M Law, et al.
British Medical Journal|March 6, 1976
Anuria due to cystine stones in a babyM J Farr, D W Newling, A H Eldrissy, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Comparison of the effects of high dose Estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer: an interim analysis of EORTC-GU Group study no. 30865D W Newling, S Fossa, U Tunn, et al.
British Journal of Urology|June 20, 1998
Metastatic prostatic carcinoma in a male-to-female transsexualE P van Haarst, D W Newling, L J Gooren, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 21, 1999
Combination 186Re-HEDP and cisplatin supra-additive treatment effects in prostate cancer cellsA A Geldof, L de Rooij, R T Versteegh, et al.
The American Journal of Surgical Pathology|March 1, 1994
Sarcomatoid carcinoma of the urinary bladder. Clinicopathologic analysis of 18 cases with immunohistochemical and electron microscopic findingsR Torenbeek, C E Blomjous, P C de Bruin, et al.
European Urology|September 23, 1998
Sexual dysfunction associated with the management of prostate cancerJ M Fitzpatrick, R S Kirby, R J Krane, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Progress in Clinical and Biological Research|January 1, 1985
Proteinuria after intravesical chemotherapyE H Cooper, H Yu, R W Glashan, et al.
British Journal of Urology|December 1, 1988
The value of the measurement of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancerT G Armitage, E H Cooper, D W Newling, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 24, 2001
Chronic cystitis caused by Corynebacterium urealyticum detected by polymerase chain reactionA M Simoons-Smit, P H Savelkoul, D W Newling, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1992
Prognostic factors in hormone-resistant progressing cancer of the prostateS D Fosså, D P Dearnaley, M Law, et al.
British Medical Journal|March 6, 1976
Anuria due to cystine stones in a babyM J Farr, D W Newling, A H Eldrissy, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Comparison of the effects of high dose Estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer: an interim analysis of EORTC-GU Group study no. 30865D W Newling, S Fossa, U Tunn, et al.
British Journal of Urology|June 20, 1998
Metastatic prostatic carcinoma in a male-to-female transsexualE P van Haarst, D W Newling, L J Gooren, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 21, 1999
Combination 186Re-HEDP and cisplatin supra-additive treatment effects in prostate cancer cellsA A Geldof, L de Rooij, R T Versteegh, et al.
The American Journal of Surgical Pathology|March 1, 1994
Sarcomatoid carcinoma of the urinary bladder. Clinicopathologic analysis of 18 cases with immunohistochemical and electron microscopic findingsR Torenbeek, C E Blomjous, P C de Bruin, et al.
European Urology|September 23, 1998
Sexual dysfunction associated with the management of prostate cancerJ M Fitzpatrick, R S Kirby, R J Krane, et al.
Pageof 11